Key result
Troponins and CK-MB remain essential for early and accurate diagnosis of acute myocardial infarction.
Why the study?
Cardiac biomarkers are used for early diagnosis of AMI, but a comprehensive identification of these markers through literature review was needed.
Are cardiac biomarkers useful for the early diagnosis of acute myocardial infarction?
Are cardiac biomarkers useful for the early diagnosis of acute myocardial infarction?
Cardiac biomarkers such as troponins, CK-MB, myoglobin, and LDH remain essential tools for the early diagnosis of acute myocardial infarction.
Acute Myocardial Infarction (AMI) known as heart attack is one of the main cardiovascular pathologies in Brazil, being caused by genetic and environmental factors.Aiming at the diagnosis in the first symptoms of the disease, biomarkers have become a useful tool.Present a literature review to identify cardiac biomarkers used in the diagnosis of Acute Myocardial Infarction.This is a literature review using the descriptors "Cardiac Biomarkers", "Diagnosis" AND "Acute Myocardial Infarction" in the VHL, LILACS, PubMed and SCIELO databases.Enzymes are responsible for biological reactions, they together with proteins are used as markers for aim investigation.Creatine kinase fraction MB (CK-MB), Troponins, Myoglobin and Lactate dehydrogenase (LDH) can be cited.In view of the presented, it is identified that the use of cardiac biomarkers is indispensable for the early diagnosis of the first hours of myocardial lesions.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2021) conducted a review in Acute Myocardial Infarction (n=14). Cardiac biomarkers was evaluated on Diagnostic utility for acute myocardial infarction. Cardiac biomarkers, particularly Troponins and CK-MB, are essential for the early and accurate diagnosis of acute myocardial infarction within the first hours of myocardial injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: